Cargando…

Desperately seeking…Models to find the right partner and the best use for checkpoint inhibitors

Immune checkpoint inhibitors have shown unprecedented clinical activity in a variety of cancer types, but only in a fraction of patients. Promising in vivo synergies have been demonstrated between checkpoint inhibitors and other drugs and/or chemotherapy or radiotherapy, and effective models are now...

Descripción completa

Detalles Bibliográficos
Autor principal: Bertolini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342965/
https://www.ncbi.nlm.nih.gov/pubmed/30538261
http://dx.doi.org/10.1038/s41416-018-0353-x